NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research note issued on Sunday. The brokerage set a “sell” rating on the medical device company’s stock.

NeuroMetrix Stock Performance

NASDAQ NURO opened at $3.77 on Friday. The firm has a 50 day simple moving average of $3.94 and a 200-day simple moving average of $3.73. NeuroMetrix has a one year low of $2.70 and a one year high of $7.94. The firm has a market cap of $7.58 million, a price-to-earnings ratio of -0.60 and a beta of 2.30.

NeuroMetrix (NASDAQ:NURO) last posted its quarterly earnings data on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. NeuroMetrix had a negative net margin of 151.51% and a negative return on equity of 39.85%. The business had revenue of $1.09 million during the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC acquired a new position in shares of NeuroMetrix, Inc. (NASDAQ:NURO) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned about 2.80% of NeuroMetrix at the end of the most recent quarter. 19.40% of the stock is owned by institutional investors.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.